Federal Judge Dismisses ERISA, ACA Claims In Fentanyl Coverage Case

Mealey's (September 4, 2018, 12:25 PM EDT) -- NEW YORK — Despite plaintiffs’ conclusory legal statements, there is no evidence that a pharmacy benefits administrator acted in an arbitrary or capricious way in limiting its coverage of fentanyl to cases of breakthrough cancer pain, nor that the plan was unclear or intentionally discriminated against a woman in violation of the ACA, a federal judge held Aug. 29 (Rebecca Weinreb, et al. v. Xerox Business Services, et al., No. 16-6823, S.D. N.Y., 2018 U.S. Dist. LEXIS 147706)....